|
US2459955A
(en)
*
|
1945-10-17 |
1949-01-25 |
Shawinigan Chem Ltd |
Polyvinyl acetate emulsion adhesive
|
|
DE1420015B1
(de)
|
1959-10-16 |
1971-08-26 |
Boehringer Sohn Ingelheim |
2'-Hydroxy-5,9-dimethyl-6,7-benzomorphane
|
|
US3854480A
(en)
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
|
US3725311A
(en)
*
|
1972-05-15 |
1973-04-03 |
Thuron Industries |
Low temperature extrudable odor-neutralizing composition
|
|
US3937801A
(en)
|
1973-07-10 |
1976-02-10 |
American Home Products Corporation |
Reducing the incidence of gastrointestinal side effects during the treatment of inflammatory conditions with antiinflammatory drugs
|
|
US4015044A
(en)
*
|
1975-03-27 |
1977-03-29 |
Union Carbide Corporation |
Process of bonding polyurethane-sealants and caulks
|
|
US4115400A
(en)
|
1976-05-27 |
1978-09-19 |
Eli Lilly And Company |
1-Azoniabicyclo[3.1.0]hexanes
|
|
US4176186A
(en)
|
1978-07-28 |
1979-11-27 |
Boehringer Ingelheim Gmbh |
Quaternary derivatives of noroxymorphone which relieve intestinal immobility
|
|
JPS5535031A
(en)
|
1978-09-04 |
1980-03-11 |
Shin Etsu Chem Co Ltd |
Enteric coating composition
|
|
US4311833A
(en)
|
1979-03-06 |
1982-01-19 |
Daicel Chemical Industries Ltd. |
Process for preparing ethylcarboxymethylcellulose
|
|
US4331579A
(en)
*
|
1979-10-04 |
1982-05-25 |
Congoleum Corporation |
Adhesive to adhere impervious and felt backed vinyl sheet material to damp concrete
|
|
US4322426A
(en)
|
1980-04-28 |
1982-03-30 |
E. I. Du Pont De Nemours And Company |
17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
|
|
US4675189A
(en)
|
1980-11-18 |
1987-06-23 |
Syntex (U.S.A.) Inc. |
Microencapsulation of water soluble active polypeptides
|
|
US4466968A
(en)
|
1980-11-24 |
1984-08-21 |
Dermall, Ltd. |
Method for prophylaxis or treatment of emesis and nausea
|
|
US4427676A
(en)
|
1980-12-19 |
1984-01-24 |
John Wyeth & Brother Ltd. |
Thiomorpholine derivatives
|
|
US4376144A
(en)
*
|
1981-04-08 |
1983-03-08 |
Monsanto Company |
Treated fibers and bonded composites of cellulose fibers in vinyl chloride polymer characterized by an isocyanate bonding agent
|
|
US4377568A
(en)
|
1981-08-12 |
1983-03-22 |
Merck Sharp & Dohme (I.A.) Corp. |
Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
|
|
DK150008C
(da)
|
1981-11-20 |
1987-05-25 |
Benzon As Alfred |
Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
|
|
JPS58141225A
(ja)
*
|
1982-02-16 |
1983-08-22 |
Takasago Corp |
芳香材用樹脂組成物
|
|
WO1983003197A1
(en)
|
1982-03-16 |
1983-09-29 |
Univ Rockefeller |
Method for controlling gastrointestinal dysmotility
|
|
US4987136A
(en)
|
1982-03-16 |
1991-01-22 |
The Rockefeller University |
Method for controlling gastrointestinal dysmotility
|
|
US4457907A
(en)
|
1982-08-05 |
1984-07-03 |
Clear Lake Development Group |
Composition and method for protecting a therapeutic drug
|
|
US4518433A
(en)
|
1982-11-08 |
1985-05-21 |
Fmc Corporation |
Enteric coating for pharmaceutical dosage forms
|
|
US4452775A
(en)
|
1982-12-03 |
1984-06-05 |
Syntex (U.S.A.) Inc. |
Cholesterol matrix delivery system for sustained release of macromolecules
|
|
US4462839A
(en)
|
1983-06-16 |
1984-07-31 |
Fmc Corporation |
Enteric coating for pharmaceutical dosage forms
|
|
US4556552A
(en)
|
1983-09-19 |
1985-12-03 |
Colorcon, Inc. |
Enteric film-coating compositions
|
|
US4581456A
(en)
|
1983-09-21 |
1986-04-08 |
Eli Lilly And Company |
Processes for preparing picenadol precursors and novel intermediates thereof
|
|
US4615885A
(en)
|
1983-11-01 |
1986-10-07 |
Terumo Kabushiki Kaisha |
Pharmaceutical composition containing urokinase
|
|
US5266574A
(en)
|
1984-04-09 |
1993-11-30 |
Ian S. Zagon |
Growth regulation and related applications of opioid antagonists
|
|
US4689332A
(en)
|
1984-04-09 |
1987-08-25 |
Research Corporation |
Growth regulation and related applications of opioid antagonists
|
|
US4654390A
(en)
*
|
1984-08-10 |
1987-03-31 |
The Dow Chemical Company |
Monomeric plasticizers for halogen-containing resins
|
|
JPS6229515A
(ja)
|
1985-07-30 |
1987-02-07 |
Shinjiro Tsuji |
硬カプセル剤のフイルムコ−テイング方法
|
|
US4730048A
(en)
|
1985-12-12 |
1988-03-08 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
|
US4806556A
(en)
|
1985-12-12 |
1989-02-21 |
Regents Of The University Of Minnesota |
Gut-selective opiates
|
|
US4719215A
(en)
|
1986-03-07 |
1988-01-12 |
University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
|
US4861781A
(en)
|
1986-03-07 |
1989-08-29 |
The University Of Chicago |
Quaternary derivatives of noroxymorphone which relieve nausea and emesis
|
|
DE3609073C2
(de)
|
1986-03-18 |
1995-08-10 |
Hans J Prof Dr Rer Nat Schmitt |
Meßeinrichtung zur nichtinvasiven Feststellung peripherer Abfluß- und Durchflußstörungen in menschlichen Extremitäten
|
|
US4673679A
(en)
|
1986-05-14 |
1987-06-16 |
E. I. Du Pont De Nemours And Company |
Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
|
|
GB8711536D0
(en)
*
|
1986-05-27 |
1987-06-17 |
Ici Plc |
Sealant compositions
|
|
KR940000065B1
(ko)
|
1986-08-28 |
1994-01-05 |
코 사이 잉 토마스 |
동물 성장 촉진제
|
|
US5597564A
(en)
|
1986-08-28 |
1997-01-28 |
Enzacor Properties Limited |
Method of administering a microgranular preparation to the intestinal region of animals
|
|
US4888346A
(en)
|
1986-10-07 |
1989-12-19 |
Bernard Bihari |
Method for the treatment of persons infected with HTLV-III (AIDS) virus
|
|
FR2609632B1
(fr)
|
1987-01-21 |
1991-03-29 |
Shelly Marc |
Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
|
|
NL8700842A
(OSRAM)
|
1987-04-10 |
1988-11-01 |
Duphar Int Res |
|
|
US4891379A
(en)
|
1987-04-16 |
1990-01-02 |
Kabushiki Kaisha Kobe Seikosho |
Piperidine opioid antagonists
|
|
CA1315689C
(en)
|
1987-09-03 |
1993-04-06 |
Leon I. Goldberg |
Quarternary derivatives of noroxymorphone which relieve nausea and emesis
|
|
DE3780819T2
(de)
|
1987-09-10 |
1993-01-14 |
Univ Chicago |
Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
|
|
US5179138A
(en)
*
|
1988-01-25 |
1993-01-12 |
Chisso Corporation |
Process for producing a vinyl chloride resin composition for powder molding
|
|
US4912114A
(en)
|
1988-03-18 |
1990-03-27 |
Sandoz Ltd. |
Morphinan derivatives
|
|
EP0352361A1
(en)
|
1988-07-29 |
1990-01-31 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
|
US4857533A
(en)
|
1988-12-15 |
1989-08-15 |
Baker Cummins Pharmaceuticals, Inc. |
Method of treatment for autoimmune diseases
|
|
US4863928A
(en)
|
1989-01-04 |
1989-09-05 |
Baker Cummins Pharmaceuticals, Inc. |
Method of treatment for arthritic and inflammatory diseases
|
|
US5102887A
(en)
|
1989-02-17 |
1992-04-07 |
Arch Development Corporation |
Method for reducing emesis and nausea induced by the administration of an emesis causing agent
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US4965269A
(en)
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
|
KR970005839B1
(ko)
|
1990-05-11 |
1997-04-21 |
화이자 인코포레이티드 |
상승 치료효과를 얻기 위한 조성물 및 방법
|
|
JPH04230625A
(ja)
|
1990-12-27 |
1992-08-19 |
Standard Chem & Pharmaceut Corp Ltd |
噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
|
|
AU658401B2
(en)
|
1991-02-25 |
1995-04-13 |
Trustees Of Boston University |
Opiate receptor antagonist modulates hyperkinetic movement disorder
|
|
US5270328A
(en)
|
1991-03-29 |
1993-12-14 |
Eli Lilly And Company |
Peripherally selective piperidine opioid antagonists
|
|
US5159081A
(en)
|
1991-03-29 |
1992-10-27 |
Eli Lilly And Company |
Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
|
|
CA2064373C
(en)
|
1991-03-29 |
2005-08-23 |
Buddy Eugene Cantrell |
Piperidine derivatives
|
|
US5250542A
(en)
|
1991-03-29 |
1993-10-05 |
Eli Lilly And Company |
Peripherally selective piperidine carboxylate opioid antagonists
|
|
ES2109362T3
(es)
|
1991-06-21 |
1998-01-16 |
Univ Cincinnati |
Unas proteinas administrables oralmente y metodo para hacerlas.
|
|
US5458953A
(en)
*
|
1991-09-12 |
1995-10-17 |
Mannington Mills, Inc. |
Resilient floor covering and method of making same
|
|
US5407686A
(en)
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
US5614219A
(en)
|
1991-12-05 |
1997-03-25 |
Alfatec-Pharma Gmbh |
Oral administration form for peptide pharmaceutical substances, in particular insulin
|
|
US5985880A
(en)
|
1996-06-05 |
1999-11-16 |
Delta Pharmaceuticals |
Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
|
|
CA2130563C
(en)
|
1992-02-24 |
1997-11-11 |
Maurice W. Gittos |
2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist
|
|
US5401708A
(en)
*
|
1992-05-19 |
1995-03-28 |
Kanzaki Paper Mfg. Co., Ltd. |
Heat-sensitive recording material
|
|
US6096756A
(en)
|
1992-09-21 |
2000-08-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
|
US5580876A
(en)
|
1992-09-21 |
1996-12-03 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
|
|
US5512578A
(en)
|
1992-09-21 |
1996-04-30 |
Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists
|
|
US5472943A
(en)
|
1992-09-21 |
1995-12-05 |
Albert Einstein College Of Medicine Of Yeshiva University, |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists
|
|
USRE36547E
(en)
|
1992-09-21 |
2000-02-01 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
|
|
WO1994010202A1
(en)
|
1992-10-28 |
1994-05-11 |
Genentech, Inc. |
Vascular endothelial cell growth factor antagonists
|
|
DE69305313T3
(de)
|
1992-12-22 |
2001-06-21 |
The University Of Cincinnati, Cincinnati |
Orale Verabreichung von immunologischen aktiven Biomolekülen und anderen therapeutischen Proteinen
|
|
DE4303214A1
(de)
|
1993-02-04 |
1994-08-11 |
Wolfgang Marks |
Behandlung von Erkrankungen viraler, viroidaler oder onkogener Genese durch Steroid-Saponine oder deren Aglykone
|
|
US5656290A
(en)
|
1993-02-26 |
1997-08-12 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5391372A
(en)
|
1993-06-28 |
1995-02-21 |
Campbell; Elizabeth |
Methods of treating colic and founder in horses
|
|
GB2281205A
(en)
|
1993-08-24 |
1995-03-01 |
Euro Celtique Sa |
Oral opioid analgesic
|
|
WO1995009168A1
(en)
|
1993-09-30 |
1995-04-06 |
Tokyo Tanabe Company Limited |
Indoline compound and 5-ht3 receptor antagonist containing the same as active ingredient
|
|
US5489618A
(en)
*
|
1993-11-29 |
1996-02-06 |
Osi Specialties, Inc. |
Process for preparing polyurethane foam
|
|
US5434171A
(en)
|
1993-12-08 |
1995-07-18 |
Eli Lilly And Company |
Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
|
|
DE69503126T2
(de)
|
1994-05-05 |
1998-11-12 |
Beckman Instruments Inc |
Repetitive oligonukleotide matrix
|
|
IT1269826B
(it)
|
1994-05-24 |
1997-04-15 |
Paolo Minoia |
Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
|
|
US5536507A
(en)
|
1994-06-24 |
1996-07-16 |
Bristol-Myers Squibb Company |
Colonic drug delivery system
|
|
US5866154A
(en)
|
1994-10-07 |
1999-02-02 |
The Dupont Merck Pharmaceutical Company |
Stabilized naloxone formulations
|
|
US5614222A
(en)
|
1994-10-25 |
1997-03-25 |
Kaplan; Milton R. |
Stable aqueous drug suspensions and methods for preparation thereof
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
ES2094694B1
(es)
|
1995-02-01 |
1997-12-16 |
Esteve Quimica Sa |
Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
|
|
US5519072A
(en)
*
|
1995-02-15 |
1996-05-21 |
National Starch And Chemical Investment Holding Corporation |
Aqueous adhesive compositions for use in binding books
|
|
US6096763A
(en)
|
1995-02-23 |
2000-08-01 |
Merck & Co., Inc. |
α1a adrenergic receptor antagonists
|
|
US6025154A
(en)
|
1995-06-06 |
2000-02-15 |
Human Genome Sciences, Inc. |
Polynucleotides encoding human G-protein chemokine receptor HDGNR10
|
|
US5900464A
(en)
*
|
1995-07-25 |
1999-05-04 |
Fmc Corporation |
Processes for making methacrylate and acrylate polymers
|
|
US5750278A
(en)
*
|
1995-08-10 |
1998-05-12 |
Westinghouse Electric Corporation |
Self-cooling mono-container fuel cell generators and power plants using an array of such generators
|
|
US5821219A
(en)
|
1995-08-11 |
1998-10-13 |
Oregon Health Sciences University |
Opioid antagonists and methods of their use
|
|
US5736152A
(en)
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
|
US5804595A
(en)
|
1995-12-05 |
1998-09-08 |
Regents Of The University Of Minnesota |
Kappa opioid receptor agonists
|
|
DK0914097T3
(da)
|
1996-03-12 |
2002-04-29 |
Alza Corp |
Sammensætning og doseringsform omfattende opioid antagonist
|
|
US6136780A
(en)
|
1996-03-29 |
2000-10-24 |
The Penn State Research Foundation |
Control of cancer growth through the interaction of [Met5 ]-enkephalin and the zeta (ζ) receptor
|
|
US20040024006A1
(en)
|
1996-05-06 |
2004-02-05 |
Simon David Lew |
Opioid pharmaceutical compositions
|
|
US5856369A
(en)
*
|
1996-07-30 |
1999-01-05 |
Osi Specialties, Inc. |
Polyethers and polysiloxane copolymers manufactured with double metal cyanide catalysts
|
|
JP3648864B2
(ja)
|
1996-08-28 |
2005-05-18 |
三菱自動車工業株式会社 |
希薄燃焼内燃機関
|
|
DE19651551C2
(de)
|
1996-12-11 |
2000-02-03 |
Klinge Co Chem Pharm Fab |
Opioidantagonisthaltige galenische Formulierung
|
|
US20010036469A1
(en)
|
1997-01-13 |
2001-11-01 |
Gooberman Lance L. |
Opiate antagonist implant and process for preparation therefor
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US6858260B2
(en)
*
|
1997-05-21 |
2005-02-22 |
Denovus Llc |
Curable sealant composition
|
|
GB9801231D0
(en)
|
1997-06-05 |
1998-03-18 |
Merck & Co Inc |
A method of treating cancer
|
|
HU9701081D0
(en)
|
1997-06-23 |
1997-08-28 |
Gene Research Lab Inc N |
Pharmaceutical composition of antitumoral activity
|
|
US6525038B1
(en)
|
1997-06-24 |
2003-02-25 |
Werner Kreutz |
Synergistic compositions for the selective control of tumor tissue
|
|
US6353004B1
(en)
|
1997-07-14 |
2002-03-05 |
Adolor Coporation |
Peripherally acting anti-pruritic opiates
|
|
US6096764A
(en)
|
1997-08-21 |
2000-08-01 |
Eli Lilly And Company |
Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration
|
|
US20030158220A1
(en)
|
1997-11-03 |
2003-08-21 |
Foss Joseph F. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side effects
|
|
US6274591B1
(en)
|
1997-11-03 |
2001-08-14 |
Joseph F. Foss |
Use of methylnaltrexone and related compounds
|
|
US6559158B1
(en)
|
1997-11-03 |
2003-05-06 |
Ur Labs, Inc. |
Use of methylnaltrexone and related compounds to treat chronic opioid use side affects
|
|
US5972954A
(en)
|
1997-11-03 |
1999-10-26 |
Arch Development Corporation |
Use of methylnaltrexone and related compounds
|
|
US6777534B1
(en)
|
1997-12-09 |
2004-08-17 |
Children's Medical Center Corporation |
Peptide antagonists of vascular endothelial growth factor
|
|
PT1685839E
(pt)
|
1997-12-22 |
2013-07-08 |
Euro Celtique Sa |
Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
|
|
EP0930334A1
(en)
|
1998-01-16 |
1999-07-21 |
Quest International B.V. |
Polysaccharide conjugate capable of binding cellulose
|
|
DE69931766T2
(de)
|
1998-04-03 |
2007-05-31 |
Ajinomoto Co., Inc. |
Antitumorale mittel
|
|
US6359111B1
(en)
|
1998-05-28 |
2002-03-19 |
Neorx Corporation |
Opioid receptor targeting
|
|
HN1999000149A
(es)
|
1998-09-09 |
2000-01-12 |
Pfizer Prod Inc |
Derivados de 4,4-biarilpiperidina
|
|
EP1533328B1
(en)
*
|
1998-09-14 |
2008-01-02 |
Kaneka Corporation |
Curable compositions
|
|
US20010010919A1
(en)
|
1998-10-13 |
2001-08-02 |
David K. Grandy |
Opioid antagonists and methods of their use
|
|
US6034168A
(en)
*
|
1998-10-23 |
2000-03-07 |
Ato Findley, Inc. |
Hot melt adhesive having controllable water solubility
|
|
US6194382B1
(en)
|
1999-03-03 |
2001-02-27 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists
|
|
JP4049477B2
(ja)
|
1999-03-23 |
2008-02-20 |
大鵬薬品工業株式会社 |
副作用軽減剤
|
|
US6231849B1
(en)
*
|
1999-03-25 |
2001-05-15 |
George A. Schiller |
Simulated seminal fluid
|
|
US7129265B2
(en)
|
1999-04-23 |
2006-10-31 |
Mason R Preston |
Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
|
|
US6171620B1
(en)
|
1999-04-27 |
2001-01-09 |
Health Research, Inc. |
Method of enhancing the efficacy of anti-tumor agents
|
|
WO2000066125A1
(en)
|
1999-04-29 |
2000-11-09 |
Aventis Pharma S.A. |
Method for treating cancer using camptothecin derivatives and 5-fluorouracil
|
|
US6765010B2
(en)
|
1999-05-06 |
2004-07-20 |
Pain Therapeutics, Inc. |
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
|
|
US6833349B2
(en)
|
1999-06-08 |
2004-12-21 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating inflammatory skin diseases
|
|
US20020068712A1
(en)
|
1999-07-23 |
2002-06-06 |
Troy Stevens |
Use of decreasing levels of functional transient receptor potential gene product
|
|
US20030105121A1
(en)
|
1999-07-27 |
2003-06-05 |
Bernard Bihari |
Method of preventing lipodystrophy syndrome or reversing a pre-existing syndrome in HIV-infected patients being treated with antiretroviral agents
|
|
AU6934400A
(en)
|
1999-08-25 |
2001-03-19 |
Barrett R. Cooper |
Compositions and methods for treating opiate intolerance
|
|
US6451806B2
(en)
|
1999-09-29 |
2002-09-17 |
Adolor Corporation |
Methods and compositions involving opioids and antagonists thereof
|
|
CZ299726B6
(cs)
|
1999-11-01 |
2008-11-05 |
|
Lécivo pro lécení zácpy a syndromu dráždivého tracníku
|
|
EP1097720B1
(en)
|
1999-11-04 |
2005-10-12 |
Institut Gustave Roussy |
Antiviral agent in combination with radiation therapy for use in treatment of cancer
|
|
AU4136901A
(en)
|
1999-11-29 |
2001-06-18 |
Adolor Corporation |
Novel methods for the treatment and prevention of dizziness and pruritus
|
|
US6384044B1
(en)
|
1999-11-29 |
2002-05-07 |
Bernard Bihari |
Method of treating cancer of the prostate
|
|
DE60042282D1
(de)
|
1999-11-29 |
2009-07-09 |
Adolor Corp |
Neue methoden und verfahren zur behandlung und vermeidung von ileus
|
|
US6469030B2
(en)
|
1999-11-29 |
2002-10-22 |
Adolor Corporation |
Methods for the treatment and prevention of ileus
|
|
DE60032940T2
(de)
|
1999-11-29 |
2007-11-08 |
Adolor Corp. |
Neue verfahren und zubereitungen die opioiden und deren antagonisten enthalten
|
|
US7208464B2
(en)
*
|
2000-06-02 |
2007-04-24 |
The Procter & Gamble Company |
Fragrance compositions
|
|
US6545010B2
(en)
|
2000-03-17 |
2003-04-08 |
Aventis Pharma S.A. |
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
|
|
US20010046968A1
(en)
*
|
2000-03-23 |
2001-11-29 |
Zagon Ian S. |
Opioid growth factor modulates angiogenesis
|
|
DE10015981A1
(de)
*
|
2000-03-30 |
2001-10-11 |
Beiersdorf Ag |
Herstellung von Acrylat-Schmelzhaftklebern aus wässrigen dispersen Systemen
|
|
US6967075B2
(en)
|
2000-04-07 |
2005-11-22 |
Schering Corporation |
HCV replicase complexes
|
|
WO2001078781A2
(en)
|
2000-04-19 |
2001-10-25 |
Johns Hopkins University |
Methods for prevention and treatment of gastrointestinal disorders
|
|
AU5945801A
(en)
|
2000-05-05 |
2001-11-20 |
Pain Therapeutics Inc |
Opoid antagonist compositions and dosage forms
|
|
AU2001264665A1
(en)
*
|
2000-05-19 |
2001-12-03 |
Henkel Loctite Corporation |
Impregnation sealants utilizing hydrosilation chemistry
|
|
DE60139689D1
(de)
|
2000-06-22 |
2009-10-08 |
Univ Iowa Res Found |
Kombination von CpG und Antikörpern gegen CD19,CD20,CD22 oder CD40 zur Prävention oder Behandlung von Krebs.
|
|
EP1175905A1
(en)
|
2000-07-24 |
2002-01-30 |
Societe Des Produits Nestle S.A. |
Nutritional Composition
|
|
AU2001289699B2
(en)
|
2000-07-28 |
2006-06-01 |
Cheplapharm Arzneimittel Gmbh |
New pharmaceutical composition
|
|
US6706399B1
(en)
*
|
2000-08-29 |
2004-03-16 |
Eastman Chemical Company |
Non-blocking polymeric articles
|
|
US6414016B1
(en)
|
2000-09-05 |
2002-07-02 |
Sucampo, A.G. |
Anti-constipation composition
|
|
WO2002060870A2
(en)
|
2000-11-17 |
2002-08-08 |
Adolor Corporation |
Delta agonist analgesics
|
|
NZ543940A
(en)
|
2000-12-04 |
2008-04-30 |
Primagen B V |
Determining the ratio of genomic DNA and mtDNA or their related gene products with regards to determining the stage of an asymptomatic disease
|
|
AU2002239384B2
(en)
|
2000-12-13 |
2007-01-11 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
US6693125B2
(en)
|
2001-01-24 |
2004-02-17 |
Combinatorx Incorporated |
Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
|
|
US20020172712A1
(en)
|
2001-03-19 |
2002-11-21 |
Alan Drizen |
Antiemetic, anti-motion sustained release drug delivery system
|
|
AU2002252444A1
(en)
*
|
2001-03-23 |
2002-10-08 |
Board Of Regents, The University Of Texas System |
Methods for inhibition of angiogenesis, tumor growth and metastasis by fully human anti-il8 and anti-muc18 in diverse types of tumors
|
|
US6800639B2
(en)
|
2001-03-23 |
2004-10-05 |
Shire Biochem Inc. |
Pharmaceutical combination for the treatment of cancer
|
|
US6846929B2
(en)
*
|
2001-04-02 |
2005-01-25 |
Ciba Specialty Chemicals Corporation |
Benzotriazole/hals molecular combinations and compositions stabilized therewith
|
|
US20040242523A1
(en)
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
|
EP2283845A1
(en)
|
2001-04-26 |
2011-02-16 |
pSivida Inc. |
Sustained release drug delivery system containing codrugs
|
|
TWI302100B
(en)
|
2001-05-02 |
2008-10-21 |
Sucampo Ag |
Composition for treating drug-induced constipation
|
|
EP1404323B1
(en)
|
2001-06-05 |
2009-10-28 |
The University of Chicago |
Use of methylnaltrexone to treat immune suppression
|
|
US6675560B2
(en)
*
|
2001-06-29 |
2004-01-13 |
Eastman Chemical Company |
PVC food wrap formed from dioctyl terphthalate plasticizer, method of forming same and method of wrapping food therewith
|
|
DE60221130T2
(de)
*
|
2001-07-16 |
2008-03-13 |
F. Hoffmann-La Roche Ag |
2 pyrrolidon-derivate als prostanoid-agonisten
|
|
EP1432429A4
(en)
*
|
2001-08-31 |
2005-09-21 |
Univ Louisiana State |
ANGIOGENIC INHIBITION AND DESTRUCTION OF ANGIOGENIC VACUUM WITH EXTRACTS OF NONI JUICE (MORINDA CITRIFOLIA)
|
|
WO2003030912A1
(en)
|
2001-08-31 |
2003-04-17 |
Sucampo Ag |
Prostaglandin analogs as chloride channel opener
|
|
US7012148B2
(en)
*
|
2001-09-25 |
2006-03-14 |
Trustees Of Dartmouth College |
Compositions and methods for thionation during chemical synthesis reactions
|
|
US7056500B2
(en)
|
2001-10-18 |
2006-06-06 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of opioid antagonists
|
|
US20030144312A1
(en)
|
2001-10-30 |
2003-07-31 |
Schoenhard Grant L. |
Inhibitors of ABC drug transporters in multidrug resistant cancer cells
|
|
WO2003037365A1
(en)
|
2001-11-01 |
2003-05-08 |
The Johns Hopkins University |
Methods and compositions for treating vascular leak using hepatocyte growth factor
|
|
TWI331920B
(en)
|
2001-11-14 |
2010-10-21 |
Sucampo Ag |
Unit dosage form for relieving or treating constipation in human patients
|
|
TWI263505B
(en)
|
2001-11-19 |
2006-10-11 |
Sucampo Ag |
Pharmaceutical composition comprising a C1C-2 channel opener
|
|
US6855765B2
(en)
*
|
2001-12-12 |
2005-02-15 |
National University Of Singapore |
Heat and hot water resistant polyurethane sealant
|
|
US7371767B2
(en)
|
2001-12-21 |
2008-05-13 |
Merck & Co., Inc. |
Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
|
|
US20050011468A1
(en)
|
2002-02-04 |
2005-01-20 |
Jonathan Moss |
Use of methylnaltrexone in treating gastrointestinal dysfunction in equines
|
|
CA2475305A1
(en)
|
2002-02-04 |
2004-02-19 |
Jonathan Moss |
Use of methylnaltrexone in treating gastrointestinal dysfunction in equines
|
|
IL148244A0
(en)
|
2002-02-19 |
2002-09-12 |
Yissum Res Dev Co |
Anti-nausea and anti-vomiting activity of cannabidiol compounds
|
|
US7074825B2
(en)
|
2002-03-07 |
2006-07-11 |
Huanbiao Mo |
Composition and method for treating cancer
|
|
US20030191147A1
(en)
|
2002-04-09 |
2003-10-09 |
Barry Sherman |
Opioid antagonist compositions and dosage forms
|
|
US7355081B2
(en)
|
2002-04-17 |
2008-04-08 |
The University Of North Carolina At Chapel Hill |
Curcumin analogues and uses thereof
|
|
WO2003099833A2
(en)
*
|
2002-05-17 |
2003-12-04 |
Board Of Regents, The University Of Texas System |
Beta-2-glycoprotein 1 is an inhibitor of angiogenesis
|
|
US7012100B1
(en)
|
2002-06-04 |
2006-03-14 |
Avolix Pharmaceuticals, Inc. |
Cell migration inhibiting compositions and methods and compositions for treating cancer
|
|
EP1803821B1
(en)
|
2002-06-05 |
2012-02-29 |
Cedars-Sinai Medical Center |
Methods for managing kinase inhibitor therapy
|
|
WO2004007503A1
(ja)
|
2002-07-11 |
2004-01-22 |
Toray Industries, Inc. |
悪心・嘔吐の治療または予防剤
|
|
US7160913B2
(en)
|
2002-09-13 |
2007-01-09 |
Thomas Jefferson University |
Methods and kit for treating Parkinson's disease
|
|
US7691374B2
(en)
|
2002-10-23 |
2010-04-06 |
Health Research, Inc. |
Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody
|
|
MXPA05004759A
(es)
|
2002-11-08 |
2005-08-02 |
Mallinckrodt Inc |
Proceso para la preparacion de sales alcaloides n-alquil morfinan cuaternarias.
|
|
WO2004054569A1
(en)
|
2002-12-16 |
2004-07-01 |
Council Of Scientific And Industrial Research |
Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings
|
|
US20060281682A1
(en)
|
2003-01-28 |
2006-12-14 |
Currie Mark G |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
WO2004066987A2
(en)
|
2003-01-30 |
2004-08-12 |
Dynogen Pharmaceuticals, Inc. |
Use of sodium channel modulators for treating gastrointestinal tract disorders
|
|
ATE406360T1
(de)
*
|
2003-03-07 |
2008-09-15 |
Lilly Co Eli |
Antagonisten der opioidrezeptoren
|
|
ES2528669T3
(es)
|
2003-04-08 |
2015-02-11 |
Progenics Pharmaceuticals, Inc. |
Formulaciones farmacéuticas que contienen metilnaltrexona
|
|
CA2521369A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals, Inc. |
The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
|
|
BRPI0409125A
(pt)
|
2003-04-08 |
2006-03-28 |
Progenics Pharm Inc |
terapia de combinação para constipação compreendendo um laxativo e um antagonista de opióide periférico
|
|
DE602004012403T2
(de)
|
2003-04-29 |
2009-03-19 |
Orexigen Therapeutics, Inc., La Jolla |
Zusammensetzungen zur beeinflussung des gewichtsverlusts
|
|
US6992193B2
(en)
|
2003-06-10 |
2006-01-31 |
Adolor Corporation |
Sulfonylamino phenylacetamide derivatives and methods of their use
|
|
US7494979B2
(en)
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
|
CA2529307C
(en)
|
2003-06-13 |
2013-12-24 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
AU2003903387A0
(en)
|
2003-07-02 |
2003-07-17 |
Sirtex Medical Limited |
Combination therapy for treatment of neoplasia
|
|
CA2543077A1
(en)
|
2003-10-29 |
2005-05-12 |
Allez Physionix Ltd. |
Method and apparatus for determining an ultrasound fluid flow centerline
|
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
|
US6984403B2
(en)
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
|
WO2005087208A2
(en)
|
2004-03-10 |
2005-09-22 |
Trustees Of Tufts College |
Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
|
|
TW200533339A
(en)
|
2004-03-16 |
2005-10-16 |
Bristol Myers Squibb Co |
Therapeutic synergy of anti-cancer compounds
|
|
US6946556B1
(en)
|
2004-05-21 |
2005-09-20 |
Acura Pharmaceuticals, Inc. |
Preparation of opioid analgesics by a one-pot process
|
|
US7094775B2
(en)
|
2004-06-30 |
2006-08-22 |
Bone Care International, Llc |
Method of treating breast cancer using a combination of vitamin D analogues and other agents
|
|
US7388008B2
(en)
|
2004-08-02 |
2008-06-17 |
Ambrilia Biopharma Inc. |
Lysine based compounds
|
|
US20060063792A1
(en)
|
2004-09-17 |
2006-03-23 |
Adolor Corporation |
Substituted morphinans and methods of their use
|
|
US20060204512A1
(en)
|
2004-09-23 |
2006-09-14 |
Vasgene Therapeutics, Inc. |
Polypeptide compounds for inhibiting angiogenesis and tumor growth
|
|
CN101137378A
(zh)
|
2005-01-20 |
2008-03-05 |
普罗热尼奇制药公司 |
甲基纳曲酮和相关化合物治疗术后胃肠功能障碍的用途
|
|
US8524731B2
(en)
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
CA2600350C
(en)
*
|
2005-03-07 |
2015-02-10 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
|
AR057035A1
(es)
|
2005-05-25 |
2007-11-14 |
Progenics Pharm Inc |
SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
|
|
AR057325A1
(es)
|
2005-05-25 |
2007-11-28 |
Progenics Pharm Inc |
Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
|
|
EP1901742A2
(en)
*
|
2005-06-03 |
2008-03-26 |
The University of Chicago |
Modulation of cell barrier dysfunction
|
|
US20080194611A1
(en)
|
2005-06-03 |
2008-08-14 |
Alverdy John C |
Modulation of Cell Barrier Dysfunction
|
|
WO2006132963A2
(en)
|
2005-06-03 |
2006-12-14 |
The University Of Chicago |
Modulation of microbial pathogen-host cell interactions
|
|
EP1906951A4
(en)
|
2005-07-01 |
2009-05-27 |
Dynogen Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL HYPOMOTILITY AND RELEVANT DISEASES
|
|
US7343834B2
(en)
*
|
2005-07-15 |
2008-03-18 |
Howlett Marc K |
Beverage holder
|
|
PE20070207A1
(es)
|
2005-07-22 |
2007-03-09 |
Genentech Inc |
Tratamiento combinado de los tumores que expresan el her
|
|
US20090253634A1
(en)
|
2005-08-19 |
2009-10-08 |
Microbia, Inc. |
Methods and Compositions for the Treatment of Gastrointestinal Disorders
|
|
AU2006287070A1
(en)
|
2005-08-30 |
2007-03-08 |
Queen's University At Kingston |
Potentiation of the therapeutic action of an opioid receptor agonist and/or inhibition or reversal of tolerance to an opioid receptoi agonists using an ultralow dose of an alpha-2 receptor antagonist
|
|
US20070099988A1
(en)
|
2005-10-31 |
2007-05-03 |
Indevus Pharmaceuticals, Inc. |
Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
|
|
US20070259939A1
(en)
|
2006-05-04 |
2007-11-08 |
Accelerated Technologies |
Using naltrexone as a multi-purpose health supplement to improve the human condition and preventing multiple diseases and infirmities by stimulating immune system vitality and robustness
|
|
PL2057243T3
(pl)
*
|
2006-08-30 |
2013-04-30 |
Eastman Chem Co |
Kompozycje szczeliwa z nowym plastyfikatorem
|
|
KR101374888B1
(ko)
*
|
2007-07-20 |
2014-03-13 |
한양대학교 산학협력단 |
접착조성물, 접착조성물의 제조방법, 표시장치 및표시장치의 제조방법
|
|
WO2009045985A1
(en)
|
2007-10-01 |
2009-04-09 |
The University Of Chicago |
Treatment of drug-induced nausea with opioid antagonists
|
|
JP5595278B2
(ja)
|
2007-12-05 |
2014-09-24 |
ザ ユニヴァーシティー オヴ シカゴ |
オピオイド拮抗薬による薬物誘発性嘔気の治療
|
|
EP2252150B1
(en)
|
2008-02-14 |
2018-04-11 |
Alkermes, Inc. |
Selective opioid compounds
|